[The WHO program against leprosy].
作者信息
Sansarricq M
出版信息
Acta Leprol. 1982 Jan-Jun(86-87):1-13.
PMID:6815978
Abstract
摘要
相似文献
1
[The WHO program against leprosy].[世界卫生组织防治麻风病规划]
Acta Leprol. 1982 Jan-Jun(86-87):1-13.
2
The leprosy problem in the South Pacific.
N Z Med J. 2014 May 23;127(1394):91-3.
3
Partnership for sustainable leprosy control beyond 2005.2005年后可持续麻风病防治伙伴关系。
Lepr Rev. 2005 Sep;76(3):194-7.
4
WHO experience in the therapeutic control of leprosy.世界卫生组织在麻风病治疗控制方面的经验。
Int J Lepr Other Mycobact Dis. 1971 Oct-Dec;39(4):885-9.
5
[Prevalence of dapsone-resistant leprosy in Burundi. Temporary results].[布隆迪耐氨苯砜麻风病的患病率。临时结果]
Acta Leprol. 1982 Jan-Jun(86-87):29-33.
6
WHO expert committee on leprosy.
World Health Organ Tech Rep Ser. 1970;459:3-31.
7
[Leprosy control by WHO. 5. Therapy of leprosy].[世界卫生组织的麻风病防治。5. 麻风病的治疗]
Repura. 1973 Jul-Sep;42(2):178-85.
8
Success of the WHO multidrug therapy?世界卫生组织的多药疗法是否成功？
Trop Geogr Med. 1994;46(2):61-4.
9
The Kellersberger Memorial Lecture, 1981. The general situation of leprosy in the world.1981年凯勒伯格纪念讲座。世界麻风病总体情况。
Ethiop Med J. 1982 Apr;20(2):89-106.
10
Primary dapsone resistance in Cebu, The Philippines; cause for concern.菲律宾宿务市的氨苯砜原发性耐药；令人担忧的原因。
Int J Lepr Other Mycobact Dis. 1996 Sep;64(3):253-6.
Zotero 插件